Home / Bio-technology / Global Artificial T- cell receptors Market

Global Artificial T- cell receptors Market

  • Id : RNR-90958
  • Category : Bio-technology
  • Publish Date : June 2017
  • Pages : 190
  • Format : PDF
License Type

The global artificial T-cell receptors market is expected to grow with a CAGR of 44% during the forecast period 2016-2023. The increasing applications of artificial t cell receptors is one of the key factors adding growth in the global artificial T-cell receptors market. the artificial T cell receptors can control affinity of T cell receptors that increase its adoption in application such as drug discovery. Drug discovery is the key application for artificial T-cell receptors market. Personalized medicines have some biological content that allows them to be more effective and have less adverse effects that rises its demand for the treatment of chronic disorders such as cancer, etc. The rising demand for personalized medicine is the key factor that is increasing the demand from drug and discovery application. Furthermore, increasing prevalence of chronic disorders such as cancer, cardiovascular disorders, etc. and increasing incidences of immunological disorders such as Chronic granulomatous disease is adding meaningful growth in global artificial T cell receptors market. As per WHO, by the end of 2020 there will be approx. $15 million people who are expected to have cancer which is rising by approximately 50%. According to Nation Cancer Institute, the breast cancer is one of the most common cancer in women across the globe. However, stringent government regulation and long duration of trials is restricting the growth of the global artificial T cell receptor market. 

Geographically, North America held large market share in terms of revenue in 2016 in global artificial t-cell receptors market,. Rapid rise in research and development (R&D) investment in artificial t-cell receptors by private players and governments across the globe is one of the key factor which is attributing towards the large share of North American market. Moreover, the presence of various key players such as Adaptive Biotech (US), Elli Lilly (US), Pfizer (US), etc. are also adding meaning full growth in the North America artificial T-cell receptors market.